• DARA BioSciences Inc., of Raleigh, N.C., raised $4.8 million through a public offering of stock and warrants. The company sold 4,800 units priced at $1 ,000 apiece, with each unit consisting of one Series A share convertible into 400 common shares, one Class A warrant to purchase 200 common shares, and one Class B warrant to purchase 200 shares. Ladenburg Thalmann & Co. Inc. served as the placement agent. Proceeds will support DARA's pain and diabetes programs. Shares of DARA (NASDAQ:DARA) fell 33 cents, or 11 percent, to close at $2.78 on Wednesday.